US4801726A
(en)
|
1986-04-15 |
1989-01-31 |
Northeastern University |
Repetitive hit-and-run immunoassay and stable support-analyte conjugates; applied to T-2 toxin
|
US5190864A
(en)
|
1986-04-15 |
1993-03-02 |
Northeastern University |
Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
|
US4937188A
(en)
|
1986-04-15 |
1990-06-26 |
Northeastern University |
Enzyme activity amplification method for increasing assay sensitivity
|
JPH07111423B2
(ja)
*
|
1986-10-01 |
1995-11-29 |
株式会社日立製作所 |
クロマトグラフのデ−タ処理方法
|
JPS6486060A
(en)
*
|
1987-09-29 |
1989-03-30 |
Shimadzu Corp |
Analysis data processor
|
US5412083A
(en)
|
1992-04-16 |
1995-05-02 |
Northeastern University |
Carbohydrate heterobifunctional cross-linking reagent
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
WO1996025425A1
(en)
|
1995-02-16 |
1996-08-22 |
Massachusetts Health Research Institute, Inc. |
Purified tetanus toxoid and toxin
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
JP3180010B2
(ja)
*
|
1995-10-13 |
2001-06-25 |
株式会社日立製作所 |
クロマトグラフ分析装置
|
KR19990056559A
(ko)
*
|
1997-12-29 |
1999-07-15 |
윤종용 |
노이즈 감소방법 및 그 장치
|
EP0964057B1
(en)
|
1998-05-11 |
2004-12-22 |
Tosoh Corporation |
Method for separating nucleic acids by means of liquid chromatography
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
US7303746B2
(en)
|
1999-06-08 |
2007-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating eye disorders with modified chimeric polypeptides
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
AU1344102A
(en)
|
2000-10-12 |
2002-04-22 |
Genentech Inc |
Reduced-viscosity concentrated protein formulations
|
US20020064860A1
(en)
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
US7101982B2
(en)
|
2001-03-30 |
2006-09-05 |
Immunex Corporation |
Control of ph transitions during chromatography
|
AU2003268210A1
(en)
|
2002-08-28 |
2004-03-19 |
Introgen Therapeutics Inc. |
Chromatographic methods for adenovirus purification
|
US7220356B2
(en)
|
2002-09-13 |
2007-05-22 |
Biogen Idec Inc. |
Method of purifying polypeptides by simulated moving bed chromatography
|
JPWO2004087761A1
(ja)
|
2003-03-31 |
2006-07-27 |
麒麟麦酒株式会社 |
ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
|
US7700097B2
(en)
|
2003-06-27 |
2010-04-20 |
Biogen Idec Ma Inc. |
Purification and preferential synthesis of binding molecules
|
ES2342539T3
(es)
|
2003-10-24 |
2010-07-08 |
Amgen, Inc. |
Proceso para la purificacion de proteinas en una fraccion de flujo-directo de cromatografia de interaccion hidrofobica.
|
US8084032B2
(en)
|
2004-01-21 |
2011-12-27 |
Ajinomoto Co., Inc. |
Purification method which prevents denaturation of an antibody
|
CA2552639C
(en)
|
2004-02-27 |
2012-05-01 |
Ge Healthcare Bio-Sciences Ab |
A process for the purification of antibodies
|
SE0400501D0
(sv)
|
2004-02-27 |
2004-02-27 |
Amersham Biosciences Ab |
Antibody purification
|
SE0400886D0
(sv)
|
2004-04-02 |
2004-04-02 |
Amersham Biosciences Ab |
Process of purification
|
US7795405B2
(en)
|
2004-08-09 |
2010-09-14 |
Guild Associates, Inc. |
Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
|
US20060027454A1
(en)
|
2004-08-09 |
2006-02-09 |
Dinovo Augustine |
Procedure for the fractionation of proteins by using sequential ion exchange and hydrophobic interaction chromatography as prefractionation steps before analysis by two dimensional electrophoresis
|
JP4831436B2
(ja)
|
2004-10-21 |
2011-12-07 |
ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ |
クロマトグラフィーリガンド
|
WO2006088650A2
(en)
|
2005-02-02 |
2006-08-24 |
Regeneron Pharmaceuticals, Inc. |
Method of treating eye injury with local administration of a vegf inhibitor
|
US20080299671A1
(en)
|
2005-12-02 |
2008-12-04 |
Ge Healthcare Bio-Sciences Ab |
Hydrophobic Interaction Chromatography
|
KR20080104160A
(ko)
|
2006-03-28 |
2008-12-01 |
에프. 호프만-라 로슈 아게 |
항-igf-1r 인간 단일클론 항체 제형
|
NZ611859A
(en)
|
2006-04-05 |
2014-12-24 |
Abbvie Biotechnology Ltd |
Antibody purification
|
LT2944306T
(lt)
|
2006-06-16 |
2021-02-25 |
Regeneron Pharmaceuticals, Inc. |
Vfgf antagonisto kompozicijos, tinkamos įvedimui intravitrealiniu būdu
|
US9766217B2
(en)
|
2006-09-08 |
2017-09-19 |
Novo Nordisk A/S |
Methods of optimizing chromatographic separation of polypeptides
|
EP2054521A4
(en)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
|
US20080299545A1
(en)
|
2007-03-06 |
2008-12-04 |
Shuyuan Zhang |
Chromatographic methods for assessing adenovirus purity
|
US8003364B2
(en)
|
2007-05-14 |
2011-08-23 |
Bavarian Nordic A/S |
Purification of vaccinia viruses using hydrophobic interaction chromatography
|
WO2009058769A1
(en)
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
NZ587161A
(en)
*
|
2008-01-25 |
2012-02-24 |
Biogen Idec Inc |
Automated system and and method for monitoring chromatography column performance by calculating performance parameters based on noise reduced process values
|
US7897405B2
(en)
*
|
2008-02-11 |
2011-03-01 |
Thermo Finnigan Llc |
Method for identifying the elution time of an analyte
|
US20090277254A1
(en)
|
2008-05-09 |
2009-11-12 |
Medlmmune, Llc |
Methods of improving packed-bed chromatography performance
|
DK2338049T3
(da)
|
2008-08-15 |
2021-03-01 |
Biogen Ma Inc |
Fremgangsmåder til evaluering af en kromatografisøjles ydeevne
|
US20100069617A1
(en)
|
2008-09-12 |
2010-03-18 |
Ge Healthcare Bio-Sciences Ab |
Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
|
CA2932207A1
(en)
|
2008-10-20 |
2010-12-09 |
Abbvie Inc. |
Isolation and purification of antibodies using protein a affinity chromatography
|
JP5856845B2
(ja)
|
2008-10-20 |
2016-02-10 |
アッヴィ・インコーポレイテッド |
抗体精製中におけるウイルスの不活性化
|
RU2560701C2
(ru)
|
2009-05-04 |
2015-08-20 |
Эббви Байотекнолоджи Лтд. |
Стабильные композиции с высокими концентрациями белков антител человека против tnf-альфа
|
DK3444335T3
(da)
|
2009-06-16 |
2021-07-26 |
Genzyme Corp |
Forbedrede fremgangsmåder til oprensning af rekombinante aav-vektorer
|
US8821879B2
(en)
|
2009-09-04 |
2014-09-02 |
Xoma Technology Ltd. |
Anti-botulism antibody coformulations
|
RS60577B1
(sr)
|
2009-10-20 |
2020-08-31 |
Abbvie Inc |
Izolacija i prečišćavanje anti-il-13 antitela upotrebom protein a afinitetne hromatografije
|
US8246833B2
(en)
|
2009-12-17 |
2012-08-21 |
Ge Healthcare Bio-Sciences Ab |
Chromatography column and maintenance method
|
KR20120118065A
(ko)
|
2010-02-12 |
2012-10-25 |
디에스엠 아이피 어셋츠 비.브이. |
단일 단위체 항체 정제
|
JP5719433B2
(ja)
*
|
2010-06-10 |
2015-05-20 |
インターナショナル・ビジネス・マシーンズ・コーポレーションInternational Business Machines Corporation |
質量スペクトルを分析するための方法、コンピュータ・プログラム、およびシステム
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
CA2815689C
(en)
|
2010-11-11 |
2016-11-22 |
Abbvie Biotechnology Ltd. |
Improved high concentration anti-tnf.alpha. antibody liquid formulations
|
EP2652491B1
(en)
|
2010-12-15 |
2017-11-29 |
Baxalta GmbH |
Eluate collection using conductivity gradient
|
US9943594B2
(en)
|
2011-10-11 |
2018-04-17 |
Sanofi Biotechnology |
Methods for the treatment of rheumatoid arthritis
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
US20140288278A1
(en)
|
2011-10-31 |
2014-09-25 |
Joseph Nti-Gyabaah |
Chromatography process for resolving heterogeneous antibody aggregates
|
ES2663946T3
(es)
|
2011-11-14 |
2018-04-17 |
Regeneron Pharmaceuticals, Inc. |
Composiciones y métodos para aumentar la masa y la fuerza muscular antagonizando específicamente GDF8 y/o Activina A
|
BR112014012005A2
(pt)
|
2011-11-21 |
2017-12-19 |
Genentech Inc |
composições, métodos, formulação farmacêutica e artigo
|
KR101498771B1
(ko)
|
2011-12-15 |
2015-03-09 |
한화케미칼 주식회사 |
항체의 정제 방법
|
DE112012005677T5
(de)
*
|
2012-01-16 |
2014-10-23 |
Leco Corporation |
Systeme und Verfahren zur Verarbeitung von Daten in chromatographischen Systemen.
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
WO2013177115A2
(en)
|
2012-05-21 |
2013-11-28 |
Abbvie Inc. |
Novel purification of human, humanized, or chimeric antibodies using protein a affinity chromatography
|
US20140154270A1
(en)
|
2012-05-21 |
2014-06-05 |
Chen Wang |
Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
|
WO2013176754A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Novel purification of antibodies using hydrophobic interaction chromatography
|
US8941405B2
(en)
|
2012-08-03 |
2015-01-27 |
International Business Machines Corporation |
FET pair based physically unclonable function (PUF) circuit with a constant common mode voltage
|
JP6465800B2
(ja)
|
2012-08-06 |
2019-02-06 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
エンベロープウイルスを不活化するための方法および組成物
|
US9650411B2
(en)
|
2012-08-07 |
2017-05-16 |
Kyowa Hakko Kirin Co., Ltd. |
Method of purifying protein
|
AU2013361587A1
(en)
|
2012-12-20 |
2015-06-18 |
Medimmune, Llc |
Liquid antibody formulation with improved aggregation properties
|
WO2014137903A2
(en)
|
2013-03-08 |
2014-09-12 |
Genzyme Corporation |
Integrated continuous manufacturing of therapeutic protein drug substances
|
EP2830651A4
(en)
|
2013-03-12 |
2015-09-02 |
Abbvie Inc |
HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
|
US10023608B1
(en)
|
2013-03-13 |
2018-07-17 |
Amgen Inc. |
Protein purification methods to remove impurities
|
SG11201504260UA
(en)
|
2013-03-14 |
2015-10-29 |
Abbvie Inc |
Low acidic species compositions and methods for producing and using the same
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
EP2970378B1
(en)
|
2013-03-15 |
2021-05-26 |
Biogen MA Inc. |
Hydrophobic interaction protein chromatography under no-salt conditions
|
US9518082B2
(en)
|
2013-03-15 |
2016-12-13 |
Alderbio Holdings Llc |
Antibody purification and purity monitoring
|
SG10201913751RA
(en)
|
2013-05-06 |
2020-03-30 |
Scholar Rock Inc |
Compositions and methods for growth factor modulation
|
US10111953B2
(en)
|
2013-05-30 |
2018-10-30 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
|
TWI682780B
(zh)
|
2013-05-30 |
2020-01-21 |
美商再生元醫藥公司 |
醫藥組成物用於製造治療與pcsk9功能獲得性突變有關之體染色體顯性高膽固醇血症的藥物之用途
|
TWI633891B
(zh)
|
2013-06-04 |
2018-09-01 |
再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
KR101569783B1
(ko)
|
2013-06-05 |
2015-11-19 |
한화케미칼 주식회사 |
항체의 정제 방법
|
US9150938B2
(en)
|
2013-06-12 |
2015-10-06 |
Orochem Technologies, Inc. |
Tagatose production from deproteinized whey and purification by continuous chromatography
|
TWI596107B
(zh)
|
2013-06-25 |
2017-08-21 |
卡地拉保健有限公司 |
單株抗體之新穎純化方法
|
WO2015035180A1
(en)
|
2013-09-05 |
2015-03-12 |
Genentech, Inc. |
Method for chromatography reuse
|
NZ756749A
(en)
|
2013-09-13 |
2022-05-27 |
Genentech Inc |
Methods and compositions comprising purified recombinant polypeptides
|
RU2016107435A
(ru)
|
2013-09-13 |
2017-10-18 |
Дженентек, Инк. |
Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
JP2016538267A
(ja)
|
2013-10-25 |
2016-12-08 |
メディミューン,エルエルシー |
抗体精製
|
US10115576B2
(en)
|
2013-12-12 |
2018-10-30 |
Waters Technologies Corporation |
Method and an apparatus for analyzing a complex sample
|
JP6260351B2
(ja)
*
|
2014-03-04 |
2018-01-17 |
株式会社島津製作所 |
クロマトグラフ用データ処理装置及びデータ処理方法
|
JO3701B1
(ar)
|
2014-05-23 |
2021-01-31 |
Regeneron Pharma |
مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي
|
FR3025515B1
(fr)
|
2014-09-05 |
2016-09-09 |
Lab Francais Du Fractionnement |
Procede de purification d'un anticorps monoclonal
|
TW201628649A
(zh)
|
2014-10-09 |
2016-08-16 |
再生元醫藥公司 |
減少醫藥調配物中微可見顆粒之方法
|
JP2017536391A
(ja)
|
2014-12-02 |
2017-12-07 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Il−6rアンタゴニストを投与することによってドライアイ疾患を治療するための方法
|
WO2016118707A1
(en)
|
2015-01-21 |
2016-07-28 |
Oncobiologics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
TWI710573B
(zh)
|
2015-01-26 |
2020-11-21 |
美商再生元醫藥公司 |
抗伊波拉病毒醣蛋白之人類抗體
|
CN104748764B
(zh)
*
|
2015-04-01 |
2017-05-24 |
清华大学 |
一种声场可视化系统中声像平面的空间角度标定方法
|
TWI756187B
(zh)
|
2015-10-09 |
2022-03-01 |
美商再生元醫藥公司 |
抗lag3抗體及其用途
|
WO2017112762A1
(en)
|
2015-12-22 |
2017-06-29 |
Regeneron Pharmaceuticals, Inc. |
Bispecific anti-cd20/anti-cd3 antibodies to treat acute lymphoblastic leukemia
|
ES2954153T3
(es)
|
2015-12-22 |
2023-11-20 |
Regeneron Pharma |
Combinación de anticuerpos anti-PD-1 y anticuerpos biespecíficos anti-CD20/anti-CD3 para tratar el cáncer
|
EP3184119A1
(en)
|
2015-12-23 |
2017-06-28 |
Themis Bioscience GmbH |
Chromatography based purification strategies for measles scaffold based viruses
|
GB201602938D0
(en)
|
2016-02-19 |
2016-04-06 |
Ucb Biopharma Sprl |
Protein purification
|
US10353868B2
(en)
*
|
2016-04-11 |
2019-07-16 |
RMC Pharmaceutical Solutions, Inc. |
Methods and systems for event based notifications
|
CN109641928B
(zh)
|
2016-06-14 |
2022-08-30 |
比奥根Ma公司 |
用于寡核苷酸纯化的疏水性相互作用色谱法
|
WO2018027195A1
(en)
|
2016-08-05 |
2018-02-08 |
Abbvie Biotherapeutics Inc. |
Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing the same
|
PL3532838T3
(pl)
*
|
2016-10-25 |
2022-10-03 |
Regeneron Pharmaceuticals, Inc. |
Metody i systemy analizy danych chromatograficznych
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
US11697670B2
(en)
|
2017-08-22 |
2023-07-11 |
Biogen Ma Inc. |
Methods for purifying antibodies having reduced high molecular weight aggregates
|
WO2019178495A1
(en)
|
2018-03-16 |
2019-09-19 |
Biogen Ma Inc. |
Methods for purifying recombinant adeno-associated viruses
|
KR20200133240A
(ko)
|
2018-03-16 |
2020-11-26 |
브리스톨-마이어스 스큅 컴퍼니 |
단백질 생산 동안의 대사 효소 활성 및 디술피드 결합 환원
|
CN112313248A
(zh)
|
2018-03-29 |
2021-02-02 |
百时美施贵宝公司 |
纯化单体单克隆抗体的方法
|
WO2019246153A1
(en)
|
2018-06-19 |
2019-12-26 |
Bristol-Myers Squibb Company |
Methods of purifying proteins using chromatography
|
TW202005694A
(zh)
|
2018-07-02 |
2020-02-01 |
美商里珍納龍藥品有限公司 |
自混合物製備多肽之系統及方法
|
WO2020023566A1
(en)
|
2018-07-25 |
2020-01-30 |
Merck Sharp & Dohme Corp. |
Methods of separating host cell lipases from a production protein in chromatographic processes
|
EP3837281A1
(en)
|
2018-08-15 |
2021-06-23 |
Bristol-Myers Squibb Company |
Protein fragmentation control strategy by re-oxidation in downstream chromatography
|
EP3876996A1
(en)
|
2018-11-05 |
2021-09-15 |
Bristol-Myers Squibb Company |
Method for purifying pegylated protein
|
WO2020172658A1
(en)
|
2019-02-24 |
2020-08-27 |
Bristol-Myers Squibb Company |
Methods of isolating a protein
|
JP2022527493A
(ja)
|
2019-03-29 |
2022-06-02 |
ブリストル-マイヤーズ スクイブ カンパニー |
クロマトグラフィー樹脂の疎水性を測定する方法
|
WO2020264411A1
(en)
|
2019-06-28 |
2020-12-30 |
Baxalta Incorporated |
Adeno-associated virus purification methods
|